Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease.
Dallocchio
C
C
Buffa
C
C
Mazzarello
P
P
D000085:Acetates / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy / Q000523:psychology*; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D000077265:Donepezil; D004359:Drug Therapy, Combination; D000077206:Gabapentin; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D010880:Piperidines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D002800:Cholinesterase Inhibitors; D003509:Cyclohexanecarboxylic Acids; D007189:Indans; D010880:Piperidines; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000077265:Donepezil